Trends in the Exploration of Therapeutic Targets for the Treatment of Endocrine, Metabolic and Immune Disorders

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|7|3|225-231

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.7, Iss.3, 2007-09, pp. : 225-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Activins, Myostatin and Related TGF-&bgr; Family Members as Novel Therapeutic Targets for Endocrine, Metabolic and Immune Disorders

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 2, 2004-06 ,pp. : 157-166

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 9, Iss. 1, 2009-03 ,pp. : 84-107

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Endocrine Metabolic Immune Disorders Drug Targeting: An Editorial Overview

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 15, Iss. 1, 2015-01 ,pp. : 1-8

Bentham Science Publishers

Access to resources Recommend Favorite

Protein kinase C isozymes as potential therapeutic targets in immune disorders

By Lee Matthew R   Duan Wei   Tan Seng-Lai  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. : 535-552

Informa Healthcare

Access to resources Recommend Favorite

Drug-Induced Endocrine and Metabolic Disorders

By Chaker Ben Salem  

Drug Safety, Vol. 30, Iss. 8, 2007-01 ,pp. : 727-728

Adis International

Access to resources Recommend Favorite